Nasdaq
KLRS
Kalaris Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.0%
- 1 month
- −13.3%
- 1 year
- +58.7%
$4.19 · Mkt cap $99.7M
At the 6 Aug 2026 close
Nasdaq
Kalaris Therapeutics, Inc.
$4.19 · Mkt cap $99.7M
At the 6 Aug 2026 close
Kalaris Therapeutics, Inc. trades under the ticker KLRS on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $99.7M. The last closing price was $4.19, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +58.7%, and −13.3% over the past month. Returns are price returns and exclude dividends.
This page exists because KLRS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.